Evive, Acrotech get FDA nod for Ryzneuta (Efbemalenograstim alfa Injection) for chemo-induced…
Neutropenia is characterised by persistently low levels of neutrophils due to the use of chemotherapy and other types of…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Ryzneuta
Aurobindo unit, Evive Biotech ink licensing pact to commercialise CIN treatment product in US
The licensing pact has been inked between Evive and Acrotech Biopharma (Acrotech), a New Jersey-based and wholly-owned subsidiary…